These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19327846)

  • 1. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.
    Imrell K; Greiner E; Hillert J; Masterman T
    J Neuroimmunol; 2009 May; 210(1-2):128-30. PubMed ID: 19327846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.
    Wu JS; Qiu W; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Neurol Sci; 2010 Jan; 288(1-2):63-7. PubMed ID: 19879597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds.
    Idiman E; Ozakbas S; Dogan Y; Kosehasanogullari G
    J Neuroimmunol; 2009 Jul; 212(1-2):121-4. PubMed ID: 19457560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
    Imrell K; Landtblom AM; Hillert J; Masterman T
    Neurology; 2006 Sep; 67(6):1062-4. PubMed ID: 17000979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
    Karrenbauer VD; Prejs R; Masterman T; Hillert J; Glaser A; Imrell K
    J Neuroimmunol; 2013 Jan; 254(1-2):170-3. PubMed ID: 22967351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
    J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of HLA DRB1*1501 and oligoclonal bands in multiple sclerosis: clinical features and disability.
    Balnytė R; Rastenytė D; Ulozienė I; Mickevičienė D; Skordenienė E; Vitkauskienė A
    Medicina (Kaunas); 2011; 47(7):368-73. PubMed ID: 22112985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.
    Qiu W; Wu JS; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Clin Neurosci; 2010 Aug; 17(8):1009-13. PubMed ID: 20580995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of cerebrospinal fluid in multiple sclerosis.
    Siritho S; Freedman MS
    J Neurol Sci; 2009 Apr; 279(1-2):21-5. PubMed ID: 19181345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
    Wu JS; Qiu W; Castley A; James I; Mastaglia FL; Christiansen FT; Carroll WM; Joseph J; Kermode AG
    Mult Scler; 2010 Jan; 16(1):15-20. PubMed ID: 19995849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
    Thangarajh M; Gomez-Rial J; Hedström AK; Hillert J; Alvarez-Cermeño JC; Masterman T; Villar LM
    Mult Scler; 2008 Nov; 14(9):1208-13. PubMed ID: 18755821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort.
    Romero-Pinel L; Martínez-Yélamos S; Bau L; Matas E; Gubieras L; María Pujal J; Morandeira F; Bas J; Arbizu T
    Eur J Neurol; 2011 Oct; 18(10):1258-62. PubMed ID: 21418440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
    Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
    Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
    J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF analysis in suspected MS: do bands aid?
    Hintzen RQ; Giovannoni G
    Neurology; 2008 Mar; 70(13 Pt 2):1059-60. PubMed ID: 18362264
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen.
    Kikuchi S; Fukazawa T; Niino M; Yabe I; Miyagishi R; Hamada T; Hashimoto SA; Tashiro K
    Neurology; 2003 Feb; 60(4):647-51. PubMed ID: 12601107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis.
    Niino M; Sato S; Fukazawa T; Yoshimura S; Hisahara S; Matsushita T; Isobe N; Yoshida K; Houzen H; Miyazaki Y; Shimohama S; Kikuchi S; Kira J
    Mult Scler; 2015 Aug; 21(9):1112-20. PubMed ID: 25583844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.